Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
n-3 fatty acids after myocardial infarction
NCT01422317Phase 3Completed
- Sponsor
- Stavanger University Hospital
- Start
- Sep 1995
- Primary completion
- Dec 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eicosapentaenoic acid + docosahexaenoic acid in myocardial infarction (MI), coronary artery disease (CAD), sponsored by Stavanger University Hospital. Started Sep 1995; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
myocardial infarction (MI)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01422317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01422317.